Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
BMS' CAR-T cracks down on lupus, achieving sustained responses
One patient had a grade 3 case of immune effector cell-associated neurotoxicity syndrome, an adverse event associated with CAR-T therapy.
Nick Paul Taylor
Nov 14, 2024 10:00am
Sanofi will deploy new AI tool in late-stage MS trials
Nov 13, 2024 7:40am
Syndax stock slips after AML drug hits midstage trial goal
Nov 12, 2024 2:00pm
Merck KGaA tumor trial hits goal, teeing up Daiichi, Ono rivalry
Nov 12, 2024 4:46am
AbbVie's $9B schizophrenia prospect flunks phase 2 trials
Nov 11, 2024 10:06am
Tango axes PRMT5 inhibitor, shifts focus to 2 sibling molecules
Nov 6, 2024 8:28am
